Anuh Pharma Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Ritesh Shah
Algemeen directeur
₹7.1m
Totale compensatie
Percentage CEO-salaris | 68.7% |
Dienstverband CEO | 8.3yrs |
Eigendom CEO | 2.3% |
Management gemiddelde ambtstermijn | 7.2yrs |
Gemiddelde ambtstermijn bestuur | 8.2yrs |
Recente managementupdates
Recent updates
Analyse CEO-vergoeding
Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹590m |
Jun 30 2024 | n/a | n/a | ₹578m |
Mar 31 2024 | ₹7m | ₹5m | ₹601m |
Dec 31 2023 | n/a | n/a | ₹543m |
Sep 30 2023 | n/a | n/a | ₹445m |
Jun 30 2023 | n/a | n/a | ₹406m |
Mar 31 2023 | ₹6m | ₹4m | ₹362m |
Dec 31 2022 | n/a | n/a | ₹355m |
Sep 30 2022 | n/a | n/a | ₹336m |
Jun 30 2022 | n/a | n/a | ₹323m |
Mar 31 2022 | ₹4m | ₹4m | ₹306m |
Dec 31 2021 | n/a | n/a | ₹225m |
Sep 30 2021 | n/a | n/a | ₹193m |
Jun 30 2021 | n/a | n/a | ₹173m |
Mar 31 2021 | ₹3m | ₹3m | ₹284m |
Dec 31 2020 | n/a | n/a | ₹266m |
Sep 30 2020 | n/a | n/a | ₹288m |
Jun 30 2020 | n/a | n/a | ₹252m |
Mar 31 2020 | ₹4m | ₹4m | ₹143m |
Dec 31 2019 | n/a | n/a | ₹205m |
Sep 30 2019 | n/a | n/a | ₹196m |
Jun 30 2019 | n/a | n/a | ₹235m |
Mar 31 2019 | ₹3m | ₹3m | ₹234m |
Dec 31 2018 | n/a | n/a | ₹213m |
Sep 30 2018 | n/a | n/a | ₹208m |
Jun 30 2018 | n/a | n/a | ₹160m |
Mar 31 2018 | ₹2m | ₹2m | ₹165m |
Compensatie versus markt: De totale vergoeding ($USD 83.62K ) Ritesh } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.62K ).
Compensatie versus inkomsten: De vergoeding van Ritesh is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Ritesh Shah (43 yo)
8.3yrs
Tenure
₹7,062,498
Compensatie
Mr. Ritesh Bipin Shah, MBA, serves as Joint Managing Director at Anuh Pharma Limited since January 8, 2021 until 2021. Mr. Shah served as Chief Executive Officer until January 8, 2021 at Anuh Pharma Ltd an...
Leiderschapsteam
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Joint MD & Executive Director | no data | ₹7.06m | 2.31% ₹ 240.4m | |
Joint MD & Executive Director | 3.8yrs | ₹7.18m | 2.33% ₹ 243.4m | |
Non-Executive Vice Chairman of the Board | 37.2yrs | ₹415.00k | 14.68% ₹ 1.5b | |
Chief Financial Officer | 10.5yrs | ₹3.60m | geen gegevens | |
Assistant General Manager of Technical | no data | geen gegevens | geen gegevens | |
Company Secretary & Compliance Officer | less than a year | geen gegevens | geen gegevens | |
Vice President of Marketing | no data | geen gegevens | geen gegevens |
7.2yrs
Gemiddelde duur
51.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 506260 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7.2 jaar).
Bestuursleden
Naam | Positie | Tenure | Compensatie | Eigendom |
---|---|---|---|---|
Joint MD & Executive Director | 8.3yrs | ₹7.06m | 2.31% ₹ 240.4m | |
Joint MD & Executive Director | 8.2yrs | ₹7.18m | 2.33% ₹ 243.4m | |
Non-Executive Vice Chairman of the Board | 37.2yrs | ₹415.00k | 14.68% ₹ 1.5b | |
Non- Independent & Non- Executive Chairman | 16.1yrs | ₹490.00k | 0.0022% ₹ 229.4k | |
Non-Executive Director | 44.1yrs | ₹190.00k | 3.73% ₹ 388.5m | |
Non-Executive Director | 8.3yrs | ₹105.00k | 0.48% ₹ 49.8m | |
Non-Executive Director | 8.3yrs | ₹140.00k | 1.72% ₹ 179.4m | |
Non Executive Non Independent Director | 1.3yrs | ₹105.00k | 3.19% ₹ 333.0m | |
Independent Non-Executive Woman Director | 5.8yrs | ₹175.00k | 0.00014% ₹ 14.6k | |
Independent Non-Executive Director | 5.5yrs | ₹315.00k | geen gegevens | |
Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens | |
Independent Non-Executive Director | less than a year | geen gegevens | geen gegevens |
8.2yrs
Gemiddelde duur
58yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 506260 wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.2 jaar).